Brief: Cipher Pharmaceuticals And Cardiome Pharma Announce Strategic Transaction For Canadian Business Portfolio Of Cardiome

Cipher Pharmaceuticals

20/03/2018 11:32

March 20 (Reuters) - Cardiome Pharma Corp  COM.TO :
    * CIPHER PHARMACEUTICALS AND CARDIOME PHARMA ANNOUNCE
STRATEGIC
TRANSACTION FOR CANADIAN BUSINESS PORTFOLIO OF CARDIOME
    * CIPHER PHARMACEUTICALS INC - DEAL PROVIDES IMPORTANT
UPFRONT AND
NON-DILUTIVE CONSIDERATION OF $25.5 MILLION CAD
    * CIPHER PHARMACEUTICALS - ‍PROPOSED DEAL TO BE COMPLETED
PURSUANT
TO ACQUISITION BY CIPHER OF ALL OF CARDIOME SHARES, FOLLOWING
RESTRUCTURING OF CARDIOME​
    * CIPHER PHARMACEUTICALS - ‍CARDIOME SHAREHOLDERS TO GET
SHARES,
ON A ONE-FOR-ONE RATIO, OF NEWLY CREATED CANADIAN ENTITY NAMED
CORREVIO PHARMA
    * CIPHER PHARMACEUTICALS INC - BOARD OF DIRECTORS OF
CARDIOME HAS
UNANIMOUSLY APPROVED ARRANGEMENT AGREEMENT
    * CIPHER PHARMACEUTICALS INC - ‍EXPECTS TO FINANCE
ACQUISITION
WITH A COMBINATION OF CASH AND NEW DEBT​
    * CIPHER PHARMACEUTICALS - ‍ALL OF DIRECTORS AND SENIOR
OFFICERS
OF CARDIOME HAVE ENTERED INTO VOTING AND SUPPORT AGREEMENTS WITH
CIPHER​
    * CIPHER PHARMACEUTICALS - VOTING AND SUPPORT AGREEMENTS' BY
‍ALL
OF DIRECTORS AND SENIOR OFFICERS OF CARDIOME  IS TO VOTE IN
FAVOUR OF ARRANGEMENT​

Source text for Eikon:  ID:nCNWNYzFha 
Further company coverage:  COM.TO 

 ((Reuters.Briefs@thomsonreuters.com;))